Regeneron to buy 23andMe out of bankruptcy for $256 million

cbsnews.com/news/regeneron-23andme-bankruptcy-data

Regeneron, a biotech company, will acquire 23andMe for $256 million and vowed to comply with the genetic testing company's privacy policies.

This story appeared on cbsnews.com, 2025-05-19 14:16:33.
The Entire Business World on a Single Page. Free to Use →